Dark Blue Therapeutics Email Format

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Dark Blue Therapeutics is a biotechnology company focused on discovering and developing precision medicines for cancer. Based in Oxford, England, it describes itself as a small-to-mid-sized team with capabilities spanning discovery through regulatory approval, drawing on experience from biotech, large pharmaceutical companies, and investment management. The firm emphasizes applying cancer biology insights, including those associated with Oxford University, to identify targeted opportunities for therapy.

Its approach centers on matching therapies to molecularly defined patient groups, leveraging its understanding of target biology to pursue cancer targets across multiple mechanisms. The company collaborates with researchers and pharmaceutical developers seeking novel cancer therapies to address unmet patient needs and improve outcomes.

Sign up for free to view info

Company overview Employee directory